QR-Code

Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes

Abstract Aims Left ventricular hypertrophy (LVH) has been associated with an increased risk of cardiovascular (CV) disease and linked to increased morbidity and mortality. In patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), hypertension is common, and patients with these co‐morb...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Gerasimos Filippatos, Stefan D. Anker, George L. Bakris, Peter Rossing, Luis M. Ruilope, Andrew J.S. Coats, Stephan vonHaehling, Piotr Ponikowski, Giuseppe M.C. Rosano, Meike Brinker, Alfredo E. Farjat, Luke Roberts, Bertram Pitt, the FIDELIO‐DKD and FIGARO‐DKD investigators
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2025-02-01
Schriftenreihe:ESC Heart Failure
Schlagworte:
Cardiorenal outcomes
Chronic kidney disease
Finerenone
Hospitalization for heart failure
Left ventricular hypertrophy
Type 2 diabetes
Online-Zugang:https://doi.org/10.1002/ehf2.14962
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge